Shanghai Henlius Biotech

This study tested whether adding the experimental drug HLX10 to standard chemotherapy helps people with advanced small cell lung cancer live longer. 585 patients who hadn't received prior treatment were randomly assigned to receive either HLX10 plus chemotherapy or a placebo plus…

This was the first study in people to test the safety of a new drug called HLX6018. It involved 66 healthy volunteers who received a single dose to check for side effects and see how the drug moves through the body. The goal was to gather basic safety information before testing i…